"Countdown Over ATL" replaces the Peach Drop with synchronized drone and fireworks displays visible across the city. A digital drone peach begins at 11:45 p.m. Wednesday followed by 12 minutes of ...

The 7-foot tall "2026" numerals are displayed at an illumination ceremony in Times Square, Thursday, Dec. 18, 2025, in New York. (Adam Gray/AP) As we approach the new year, did you know that counting ...

Discover What’s Streaming On: Happy (almost) New Year! Before we say goodbye to 2025 and welcome 2026 with optimism, let’s talk about our streaming resolutions for the new year. For many, 2026 might ...

If you're planning on spending New Year's Eve in Atlanta this year, the celebrations are going to look a little bit different. The City of Atlanta has traded its annual Peach Drop for a new, modern ...

If you're not into crowds, streaming the New Year’s Eve fireworks from home has become a bit of an annual hack. HUNTR/X gets it — ringing in midnight from your couch is highly underrated, toasting ...

From the moment 4-year-old Cameron first stepped out into Glimmer in Spyro 2, he knew video games were going to play a central role in the rest of his life. Though he never planned to make it the ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Atlanta is replacing the traditional Peach Drop with a new citywide New Year’s Eve event called Countdown Over ATL. The celebration includes a digital drone peach and synchronized fireworks visible ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...